In this study, we demonstrated the use of readily translatable mIHC/IF methods to determine the pre-treatment expression of the 4-gene inflammatory signature and CD38 expression in the HCC tumor microenvironment. This evidence concerns the gene CD38 and hepatocellular carcinoma.